Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders-Reference-Cited by-同舟云学术

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders

Published:2023-05 Issue:5 Volume:22 Page:103312
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Konen Franz Felix,Möhn Nora,Witte Torsten,Schefzyk Matthias,Wiestler Miriam,Lovric Svjetlana,Hufendiek Karsten,Schwenkenbecher Philipp,Sühs Kurt-Wolfram,Friese Manuel A.,Klotz Luisa,Pul Refik,Pawlitzki Marc,Hagin David,Kleinschnitz Christoph,Meuth Sven G.,Skripuletz Thomas

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference307 articles.

1. Experimental allergic encephalomyelitis during and following cortone acetate treatment;Ferraro;J Neuropathol Exp Neurol,1953

2. Large dose corticosteroid therapy of experimental and human demyelinating diseases;Kibler;Ann N Y Acad Sci,1965

3. Methotrexate: suppression of experimental allergic encephalomyelitis;Brandriss;Science,1963

4. Azathioprine therapy of “autoimmune” diseases;Corley;Am J Med,1966

5. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use;Emmons;Iowa Med,1987

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro identification of single-stranded DNA aptamers targeting human IL-23 using the protein-SELEX strategy;Journal of Pharmaceutical and Biomedical Analysis;2024-09

2. Effect of Mediterranean diet on body mass index and fatigue severity in patients with multiple sclerosis: a systematic review and meta-analysis of clinical trials;Heliyon;2024-09

3. Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis;Frontiers in Immunology;2024-08-19

4. Identifying Diagnostic Markers and Constructing Predictive Models for Oxidative Stress in Multiple Sclerosis;International Journal of Molecular Sciences;2024-07-10

5. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus;Autoimmunity Reviews;2024-07